The highest heterozygous amplification ratio (45.71%) for RBX1 was found in LUSC, whereas the heterozygous amplification ratio of RBX2 presented a higher level of state in several cancers (>50%) including CESC, HNSC, LUSC and OV. The gene discussed is RBX1; the disease is cervical squamous cell carcinoma.